Amgen, Johnson & Johnson Recall Anemia Drugs With Glass Fakes

By on September 27, 2010

Amgen, Johnson & Johnson, Epogen and Procrit RecallAmgen Inc. (NASDAQ: AMGN) and Johnson & Johnson (NYSE: JNJ) announced the recall of their anemia treatment drugs, Epogen and Procrit, after finding visible glass flakes in vials containing the injectable medicines.  Amgen said the flakes are caused by the interaction of the drug with glass vials over the product’s shelf life. 

The drugs are used for treatment of anemia related to HIV therapy, chronic renal failure, and chemotherapy.

The affected product lot numbers and expiration dates can be found at http://www.epogen.com/ and http://www.procrit.com/.

AP Photo/Ed Betz

For more information, please fill out the confidential form below.